The Commission on Population commends FDA Resolution No. 2017-302 dated Nov. 10, 2017, which lifts the 29-month old Supreme Court TRO issued by the Supreme Court in June 2015. The said resolution has declared all contraceptives, including the Progestin Subdermal Implant (PSI, Implanon), non-abortifacient.
With this development, the Department of Health Secretary Francisco T. Duque III reiterated the Department’s commitment to fully implement the law to “promote the health and well-being of Filipino families by giving them access to appropriate services that allow them to attain their family life aspirations”.
According to POPCOM Executive Director Dr. Juan Antonio B. Perez III “The Commission on Population appreciates the diligence of the Food and Drug Administration in completing and approving the recertification of 51 contraceptives. This is a welcome development and at a better time as depleted contraceptive supplies will now be augmented by over 200,000 implants”.